SARS-CoV-2/COVID-19 – aktualisierte Empfehlungen zu Diagnostik und Therapie
- PMID: 33890259
- DOI: 10.1055/a-1417-7074
SARS-CoV-2/COVID-19 – aktualisierte Empfehlungen zu Diagnostik und Therapie
Conflict of interest statement
Prof. Bein hat Honorare für Vorträge und Beratertätigkeit von Pulsion/Maquet, Edwards Life Sciences und Cytosorbents erhalten. Die anderen Autorinnen/Autoren geben an, dass keine Interessenkonflikte bestehen.
Similar articles
-
Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).Clin Infect Dis. 2021 Jan 23;72(1):128-130. doi: 10.1093/cid/ciaa673. Clin Infect Dis. 2021. PMID: 32472683 Free PMC article.
-
[COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].Rev Med Suisse. 2021 Mar 31;17(732):646-652. Rev Med Suisse. 2021. PMID: 33793103 French.
-
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.Platelets. 2021 Feb 17;32(2):284-287. doi: 10.1080/09537104.2020.1859104. Epub 2020 Dec 21. Platelets. 2021. PMID: 33349108
-
Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19.Nicotine Tob Res. 2020 Dec 15;22(12 Suppl 2):S93-S95. doi: 10.1093/ntr/ntaa187. Nicotine Tob Res. 2020. PMID: 33320258 Free PMC article. Review.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical